Induction of beta cell differentiation in human cells

Abstract

The present invention provides methods for inducing insulin gene expression in cultured pancreas cells, the method comprising contacting a culture of endocrine pancreas cells expressing a PDX-1 gene and a NeuroD/BETA2 gene with a GLP-1 receptor agonist, wherein the cells have been cultured under conditions such that the cells are in contact with other cells in the culture, thereby inducing insulin gene expression in the cells. The invention also provides high throughput screening methods for modulators of β-cell function, stable cultures of cells made by the methods of the invention, and methods of treating a human subject using the methods of the invention.

1 - 35 . (canceled)  
   
   
       36 . A method of identifying a compound that modulates pancreatic cell function, the method comprising: 
 (i) expressing a recombinant NeuroD/BETA2 polynucleotide and a recombinant PDX-1 polynucleotide in pancreatic cells that have been cultured under conditions such that the cells are in contact with other cells in the culture; and    (ii) contacting the cells with a GLP-1 receptor agonist, thereby inducing insulin gene expression in the cells;    (iii) contacting the cells with a test compound; and    (iv) determining the effect of the test compound on pancreatic cell function to identify a compound that modulates pancreatic cell function.    
   
   
       37 . The method of  claim 36 , wherein the pancreatic cell function comprises insulin production.  
   
   
       38 . The method of  claim 37 , wherein the pancreatic cell function comprises glucose-responsive insulin production.  
   
   
       39 . The method of  claim 36 , wherein the GLP-1 receptor agonist is a GLP-1 analog.  
   
   
       40 . The method of  claim 36 , wherein the GLP-1 receptor agonist has an amino acid sequence of a naturally occurring peptide.  
   
   
       41 . The method of  claim 36 , wherein the GLP-1 receptor agonist is GLP-1, exendin-3, or exendin-4.  
   
   
       42 . The method of  claim 36 , wherein the cells are cultured as aggregates in suspension.  
   
   
       43 . The method of  claim 36 , wherein the cells are human cells.  
   
   
       44 . The method of  claim 36 , wherein the cells further express a recombinant oncogene.  
   
   
       45 . The method of  claim 44 , wherein the cells express more than one recombinant oncogene.  
   
   
       46 . The method of  claim 36 , wherein the cells further express a recombinant polynucleotide encoding telomerase.  
   
   
       47 . The method of  claim 36 , wherein the cells are β-cells.  
   
   
       48 . The method of  claim 47 , wherein the cells are βlox5 cells.  
   
   
       49 . The method of  claim 36 , wherein the cells are a stable culture of pancreatic cells.